Senior
Personnel
Exelar was founded by Leonard Reiffel, Ph.D. He is serving as Chairman and Chief Technical Officer. Len took public Interand Corporation (developer of such devices as the globally-used Telestrator made famous by US sportscaster John Madden on CBS and ABC).
Earlier in his career Len was Deputy Director for Sciences of the Apollo
Program at NASA Headquarters in Washington DC. Prior to joining NASA,
Dr. Reiffel was Group Vice President of the IIT Research Institute,
where he supervised a technical staff of 300 scientists and engineers.
For the
past five years, Reiffel has led the medical physics research team developing
Exelar's technology. The project has been continuously supported by
the federally-funded National Medical Technology Testbed program whose
mission
is to facilitate getting new advanced technologies into medical practice.
Dr. Reiffel is a Fellow of the American Physical Society and a member
of the Board of Overseers at his alma mater, the Illinois Institute
of Technology.
Robert J. Morton, Jr., M.S. serves as Exelar Medical's Senior Consultant in Regulatory and Quality Assurance matters. A Board-certified Medical Physicist with nearly 30 years of relevant experience, Bob is President of Quality and Regulatory Services, Inc. (QRS). He provides our team with in-depth and expert guidance concerning 510K device clearance and other FDA requirements and brings with him a wealth of medical device commercialization experience as well.
Prior to founding QRS in 1994, Bob was Manager, Regulatory Affairs and then Director, Quality Systems and Regulatory Affairs for Siemens Medical Systems - Oncology Care Systems. He was responsible for advising the cognizant Siemens Senior Executive (now Group Vice President, SMS/OCS) and his Staff on compliance with U.S. Food and Drug Administration (FDA) regulations, including Good Manufacturing Practices, for all medical devices and devices producing electronic product radiation.
From February 1985 to February 1989, Bob was Program Director and Project Officer in the Radiotherapy Development Branch, Radiation Research Program of Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
From September 1978 to May 1983, Bob was Chief of the Radiation Therapy Branch, Office of Training and Assistance Center for Devices and Radiological Health (Formerly Bureau of Radiological Health) U.S. Food and Drug Administration. Bob was FDA's Acting Deputy Director, Division of Professional Practices, Office of Training and Assistance Center for Devices and Radiological Health before joining the National Cancer Institute in 1985.
Dr. Robert Pillsbury is a leading authority in electromagnetics and the design and analysis of magnet systems for applications in fusion, maglev and plasma technologies. He has over 30 years of experience developing advanced computational algorithms and programs for the design and analysis of conventional and superconducting magnet systems. Pillsbury presented or published over 50 technical reports and publications in scholarly journals and conference proceedings.
Presently, Dr. Pillsbury is Treasurer and a Senior Consultant at Sherbrooke Consulting. Previously, he was Leader of the Electromagnetic and Structural Analysis Group of the Technology and Engineering Division of the MIT Plasma Fusion Center. The members of this group performed structural and electromagnetic analyses with applications in the areas of fusion, MHD, high energy physics accelerators and detectors, magnetic resonance imaging devices and magnetic levitation. Recent projects include: ITER, TPX, and ALCATOR CMOD tokamaks; design of detector magnets for CERN and SSC; maglev; and design and analysis of magnets for seawater propulsion and coal-fired MHD. He received his Ph. D. from the University of Texas at Austin.
Dr. Robert Pillsbury Biography
